Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew James Fry Insider Profile
4 Followers
Matthew James Fry, Director at Paradigm Biopharmaceuticals Ltd., holds 1.42M shares in Paradigm Biopharmaceuticals Ltd. (Ticker: PBIGF). Most recently, Matthew James Fry Bought $350,000 shares of Paradigm Biopharmaceuticals Ltd. on Oct 16, 2024 for an estimated value of 73.25K.
Matthew James Fry has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Matthew James Fry's holdings
Insider Roles
Director
Roles that Matthew James Fry holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Matthew James Fry
Matthew James Fry's Trading History
List of latest transactions for each holding click on a transaction to see Matthew James Fry's performance on stock
You May Also Like
Matthew James Fry insider profile FAQ
What is the percentage of profitable transactions made by Matthew James Fry?
The percentage of profitable transactions made by Matthew James Fry is ―.
What is the average return per transaction made by Matthew James Fry?
The average return per transaction made by Matthew James Fry is ―.
What stocks does Matthew James Fry hold?
Matthew James Fry holds: PBIGF stocks.
What was Matthew James Fry’s latest transaction?
Matthew James Fry latest transaction was an Informative Buy of $73.25K.
What was Matthew James Fry's most profitable transaction?
Matthew James Fry’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Matthew James Fry's role in Paradigm Biopharmaceuticals Ltd.?
Matthew James Fry's role in Paradigm Biopharmaceuticals Ltd. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.